According to Merck's latest financial reports the company's current EPS (TTM) is $1.82. In 2022 the company made an earnings per share (EPS) of $5.73 an increase over its 2021 EPS that were of $5.17.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $1.82 | -68.21% |
2022 | $5.73 | 10.92% |
2021 | $5.17 | 84.68% |
2020 | $2.80 | -27.2% |
2019 | $3.84 | 63.44% |
2018 | $2.35 | 151.11% |
2017 | $0.94 | -54.58% |
2016 | $2.06 | 30.21% |
2015 | $1.58 | -61.99% |
2014 | $4.16 | 180.51% |
2013 | $1.48 | -31.82% |
2012 | $2.18 | 6.62% |
2011 | $2.04 | 626.78% |
2010 | $0.28 | -95.05% |
2009 | $5.68 | 56.36% |
2008 | $3.63 | -449.04% |
2007 | -$1.04 | -150.98% |
2006 | $2.04 | -3.32% |
2005 | $2.11 | -20.08% |
2004 | $2.64 | -10.81% |
2003 | $2.96 | -6.92% |
2002 | $3.18 | 0% |
2001 | $3.18 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $14.09 | 673.20% | ๐บ๐ธ USA |
Novartis NVS | $3.74 | 105.30% | ๐จ๐ญ Switzerland |
Pfizer PFE | $1.86 | 2.10% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $2.97 | 63.16% | ๐บ๐ธ USA |
Eli Lilly LLY | $5.43 | 198.04% | ๐บ๐ธ USA |
Amgen AMGN | $14.15 | 676.76% | ๐บ๐ธ USA |
Sanofi SNY | $3.18 | 74.58% | ๐ซ๐ท France |
Bristol-Myers Squibb BMY | $3.97 | 117.93% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $3.50 | 92.17% | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | -$2.00 | -209.79% | ๐ฎ๐ฑ Israel |